by Table of Contents
The global automated microbiology market size was valued at USD 7.95 billion in 2024 and is expected to reach around USD 22.03 billion by 2034, a CAGR of 10.73%.
Key Takeaways
-
North America accounted for over 41% of the total market share in 2024, leading the global market.
-
Asia Pacific is projected to experience the fastest growth rate throughout the forecast period.
-
The reagents and kits segment held a dominant market share of 49% in 2024.
-
The instruments segment is expected to witness the highest CAGR in the coming years.
-
The fully automated segment led the market based on automation type in 2024.
-
The clinical diagnostics segment emerged as the largest application segment in 2024.
-
The biopharmaceutical production segment is predicted to expand at the highest CAGR over the forecast period.
-
The hospitals and diagnostic laboratories segment secured a 45% market share in 2024.
-
The pharmaceutical and biotechnology companies segment is set to grow at the fastest rate during the projected period.
AI Impact on the Automated Microbiology Market
-
Enhanced Diagnostic Accuracy: AI algorithms improve the precision of microbial identification and susceptibility testing by analyzing complex data sets. This leads to faster and more accurate diagnoses of infectious diseases.
-
Automation of Laboratory Processes: AI facilitates the automation of various laboratory workflows, reducing manual intervention and human errors. This increases efficiency and allows for high-throughput testing, essential in clinical settings.
-
Predictive Analytics: AI-driven analytics can forecast antibiotic resistance patterns, enabling healthcare providers to make informed decisions regarding treatment options. This is particularly crucial in managing antimicrobial resistance (AMR).
-
Real-time Data Processing: AI systems enable real-time monitoring and analysis of microbiological data, enhancing laboratory operations and allowing for immediate clinical decision-making.
Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview@ https://www.precedenceresearch.com/sample/5722
Growth Factors
The automated microbiology market is experiencing significant growth due to advancements in AI and automation, which enhance diagnostic accuracy, reduce manual errors, and streamline high-throughput testing. The rising prevalence of infectious diseases has increased the demand for faster and more precise diagnostic solutions, enabling early detection and timely treatment. Additionally, growing concerns over antimicrobial resistance (AMR) have emphasized the need for rapid pathogen identification, with automated microbiology providing real-time insights into resistance patterns.
The increased adoption of high-throughput testing in clinical laboratories and research institutions has further driven market expansion by improving workflow efficiency and reducing turnaround times. The rising demand for point-of-care testing (POCT), particularly in remote and resource-limited settings, has also contributed to the market’s growth by improving accessibility to diagnostic services. Government and private sector investments in healthcare infrastructure and research and development have further propelled the market forward.
Stringent regulatory and quality control requirements have led to a greater emphasis on standardized and accurate diagnostic procedures, fostering the adoption of automated microbiology solutions. Additionally, the rapid expansion of pharmaceutical and biotechnology industries has increased the need for advanced microbiology technologies for drug development, quality control, and contamination detection, further boosting market growth.
Market Scope
| Report Coverage | Details |
| Market Size by 2034 | USD 22.03 Billion |
| Market Size in 2025 | USD 8.80 Billion |
| Market Size in 2024 | USD 7.95 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 10.73% |
| Dominated Region | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
| Segments Covered | Product, Automation Type, Application, End use, and Regions |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East |
Automated Microbiology Market Dynamics
Drivers
The automated microbiology market is driven by advancements in artificial intelligence and automation, enabling faster and more accurate pathogen identification. The rising prevalence of infectious diseases has increased the demand for high-throughput microbiological testing. Additionally, the growing concerns over antimicrobial resistance have fueled the need for rapid diagnostics to guide effective treatment decisions. Increased government and private sector investments in healthcare infrastructure and laboratory automation further support market expansion.
Opportunities
The market presents significant opportunities in the development of AI-driven microbiology solutions for real-time pathogen detection and disease prediction. The increasing demand for point-of-care testing, particularly in remote areas, opens new avenues for innovation. Expanding applications in pharmaceutical and biotechnology industries, including drug development and quality control, create additional market growth prospects. Integration of cloud-based data management solutions enhances efficiency and remote access to diagnostic insights.
Challenges
Despite its growth, the automated microbiology market faces challenges such as high initial investment costs and the complexity of integrating automated systems into existing laboratory workflows. The need for skilled professionals to operate and interpret AI-driven microbiological tests is another barrier to widespread adoption. Stringent regulatory requirements and compliance issues also pose hurdles for market players.
Regional Insights
North America dominates the automated microbiology market due to advanced healthcare infrastructure, increased research funding, and the early adoption of automation technologies. Europe follows closely with strong investments in laboratory automation and stringent healthcare regulations. The Asia-Pacific region is expected to witness the fastest growth, driven by rising healthcare investments, increasing awareness of infectious disease diagnostics, and expanding pharmaceutical industries.
Automated Microbiology Market Companies
- BD
- QIAGEN
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Danaher
- Merck KGaA
- bioMérieux
- Abbott
- DiaSorin S.p.A.
- BioRad Laboratories, Inc.
Latest Announcement by Market Leaders
- In February 2025, QIAGEN announced the official opening of a new data center in Melbourne, Australia, designed to strengthen its global bioinformatics leadership position in this region of the world. This latest addition reflects QIAGEN’s ongoing commitment to enhance its bioinformatics data infrastructure.
- In January 2025, Diatech Pharmacogenetics announced an expansion of its collaboration with Merck Serono Middle East Ltd., affiliates of Merck KGaA (“Merck”). The collaboration aims to improve patient access to RAS biomarker testing in Middle East and Africa. Targeted therapy against cancer may be used in combination with chemotherapy for patients with specific genetic mutations, such as KRAS, BRAF, and NRAS mutations.
Recent Developments
- In January 2024, Rapid Micro Biosystems, Inc. announced that Samsung Biologics has chosen the Growth Direct platform to automate its microbial quality control processes, enhancing efficiency, strengthening data integrity, and enabling scalable quality control operations.
- In November 2023, London Health Sciences Centre (LHSC) and St. Joseph’s Heath Care London (St. Joseph’s) unveiled the installation of a Total Laboratory Automation (TLA) system within the clinical microbiology laboratory. The TLA system is the first of its kind to be installed in the world, making London an international flagship site for innovation in clinical microbiology.
- In January 2023, BD (Becton, Dickinson, and Company) launched a robotic track system for its BD Kiestra microbiology laboratory solution, designed to automate specimen processing, potentially minimizing manual effort and reducing result turnaround time.
Segments Covered in the Report
By Product
- Instruments
- Automated Microbial Identification Systems
- Automated Blood Culture Systems
- Automated Colony Counters
- Automated Sample Preparation Systems
- Automated Antibiotic Susceptibility Testing (AST) Systems
- Other Instruments
- Reagents and Kits
- Culture Media
- Stains and Dyes
- Assay Kits and Panels
- Others
- Software
By Automation Type
- Fully Automated
- Semi-Automated
By Application
- Biopharmaceutical Production
- Clinical Diagnostics
- Environmental and Water Testing
- Food and Beverage Testing
- Other Applications
By End-use
- Pharmaceutical and Biotechnology Companies
- Hospitals and Diagnostic Laboratories
- Academic and Research Institutes
- Other End Use
By Geography
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa
Also Read: Canine Atopic Dermatitis Market
Ready for more? Dive into the full experience on our website@ https://www.precedenceresearch.com/
